SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-015003
Filing Date
2023-04-27
Accepted
2023-04-27 07:31:35
Documents
14
Period of Report
2023-04-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20230421.htm   iXBRL 8-K 60332
2 EX-10.1 hcwb-ex10_1.htm EX-10 618515
3 GRAPHIC img171745374_0.jpg GRAPHIC 661
  Complete submission text file 0000950170-23-015003.txt   881819

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hcwb-20230421_pre.xml EX-101.PRE 10287
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hcwb-20230421_lab.xml EX-101.LAB 14018
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hcwb-20230421.xsd EX-101.SCH 2469
8 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20230421_htm.xml XML 4929
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

IRS No.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 23851924
SIC: 2834 Pharmaceutical Preparations